Scientific Literature

Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomized superiority trial

Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomized superiority trial 150 150 The Arcady Group

M4ALL Announces New Synthesis for Molnupiravir for COVID-19

M4ALL Announces New Synthesis for Molnupiravir for COVID-19 2560 1707 The Arcady Group

TB REACH Digital Adherence Technology Posters

TB REACH Digital Adherence Technology Posters 1080 1080 The Arcady Group

M4ALL Releases Processes to Scale Remdesivir Manufacturing

M4ALL Releases Processes to Scale Remdesivir Manufacturing 2560 1708 The Arcady Group

Results of World Mosquito Program Indonesia Trial

Results of World Mosquito Program Indonesia Trial 2560 1714 The Arcady Group

Temporal Factors and Missed Doses of Tuberculosis Treatment

Temporal Factors and Missed Doses of Tuberculosis Treatment 2000 1333 The Arcady Group
Back to top